Status:
COMPLETED
REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS)
Lead Sponsor:
Careggi Hospital
Conditions:
Acute Cardiac Syndrome
Stent Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of the project is to assess the long-term prognostic impact of residual platelet reactivity after optimal antiplatelet therapy in a large cohort of patients with acute coronary synd...
Detailed Description
This study is mainly based on a registry of 2000 consecutive patients with acute coronary syndrome who received invasive treatment and for whom platelet reactivity after clopidogrel treatment will be ...
Eligibility Criteria
Inclusion
- acute coronary syndrome
- invasive treatment
Exclusion
- in-hospital death that was not due to stent thrombosis,
- anticipated poor compliance to dual antipletelet treatment for at least 6 months,
- premature discontinuation of clopidogrel therapy.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
1789 Patients enrolled
Trial Details
Trial ID
NCT01231035
Start Date
September 1 2008
End Date
March 1 2011
Last Update
July 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Careggi Hospital, Department of Heart and Vessels
Florence, Italy, 50134